Inpatient management of acute alcohol withdrawal syndrome

CNS Drugs

Volumn 28, Issue 5, 2014, Pages 401-410

  Perry, Elizabeth C ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CHLORDIAZEPOXIDE; DEXMEDETOMIDINE; DIAZEPAM; GABAPENTIN; LORAZEPAM; NEUROLEPTIC AGENT; OXAZEPAM; PHENOBARBITAL; PROPOFOL; VALPROIC ACID; ANTICONVULSIVE AGENT; CENTRAL NERVOUS SYSTEM AGENTS;

ACUTE DISEASE; AGITATION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; DELIRIUM TREMENS; DISEASE CONTROL; DISEASE SEVERITY; DRUG MEGADOSE; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; LIVER DISEASE; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROPHYLAXIS; SYMPTOM ASSESSMENT; TREMOR; WITHDRAWAL SEIZURE; WITHDRAWAL SYNDROME; DISEASE MANAGEMENT; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME;

ALCOHOLISM; ANTICONVULSANTS; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM AGENTS; DISEASE MANAGEMENT; HUMANS; INPATIENTS; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84901373931     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-014-0163-5     Document Type: Article

References (28)

1. Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal. NEJM. 2003;348(18):1786-95.
2. Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655-79.
3. Carlson RW, Kumar NN, Wong-Mckinstry E, et al. Alcohol withdrawal syndrome. Crit Care Clin. 2012;28:549-85.
4. Bird RD, Makela EH. Alcohol withdrawal: what is the benzodiazepine of choice? Ann Pharmacother. 1994;28:67-71.
5. McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry. 2008;79:854-62.
6. DeBellis R, Smith BS, Choi S, Malloy M. Management of delirium tremens. J Intensive Care Med. 2005;20:164.
7. Lejoyeux M, Solomon J, Ades J. Benzodiazepine treatment for alcohol-dependent patient. Alcohol Alcohol. 1998;33(6):563-75.
8. Reoux JP, Saxon AJ, Malte CA, et al. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. Alcohol Clin Exp Res. 2001;25(9):1324-9.
9. Saitz R, O'Malley SS. Pharmacotherapies for alcohol abuse: withdrawal and treatment. Med Clin North Am. 1997;81:881.
10. Hoffman RS. Management of moderate and severe alcohol withdrawal syndromes. In: Traub SJ, editor. UpToDate. Waltham: UpToDate; 2013.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
12. Sulivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84:1353-7.
13. Wetterling T, Kanitz R, Besters B, et al. A new rating scale for the assessment of the alcohol-withdrawal syndrome (AWS Scale). Alcohol Alcohol. 1997;32(6):753-60.
14. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond agitation-sedation scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-44.
15. Mayo-Smith MF, Beecher LH, Fischer TL, et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med. 2004;164:1405.
16. Amato L, Minozzi S, Vecchi S, Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2010(3):CD005063.
17. Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ. 1999;160:649.
18. Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA. 1994;272:519.
19. Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA. 1997;278(2):144-51.
20. Kirkwood CK, Melton ST. Anxiety disorders I: generalized anxiety, panic, and social anxiety disorders. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: a pathophysiologic approach. 7th ed. New York: McGraw-Hill; 2008. p. 1161-78.
21. Peppers MP. Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease. Pharmacotherapy. 1996;16(1):49-58.
22. Rathlev NK, D'Onofrio G, Fish SS, et al. The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures. Ann Emerg Med. 1994;23:513.
23. McCowan C, Marik P. Refractory delirium tremens treated with propofol: a case series. Crit Care Med. 2000;28:1781.
24. Muzyk AJ, Fowler JA, Norwood DK, et al. Role of α2-agonists in the treatment of acute alcohol withdrawal. Ann Pharmacother. 2011;45:649-57.
25. Rayner SG, Weinert CR, Peng H, et al. Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care. 2012;2:12.
26. Minozzi S, Amato L, Vecchi S, Davoli M. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev. 2010;(3):CD005064.
27. Uzbay TI. Atypical antipsychotic drugs and ethanol withdrawal syndrome: a review. Alcohol Alcohol. 2012;47(1):33-41.
28. Keating GM. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence. Clin Drug Investig. 2014;34:63-80.